Breo Ellipta Sales Below Estimates, Says Leerink Swann (THRX) (GSK)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/27/2026

1. NVDA
2. INTU
3. DKS
4. META
5. CRM
6. ZM
7. SMTC
8. SPY
9. NCNO
10. CRWD

Go back to Breo Ellipta Sales Below Estimates, Says Leerink Swann (THRX) (GSK)
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 51.43 -0.64 (1.23%)
Previous Close $52.07    52 Week High $45.58 
Open $51.90    52 Week Low $37.82 
Day High $52.09    P/E N/A 
Day Low $51.40    EPS $0.00 
Volume 1,716,709       

Theravance, Inc. (NASDAQ: THRX) Delayed: 4.06 --0 (-0%)
Previous Close $4.06    52 Week High $21.16 
Open $0.72    52 Week Low $6.36 
Day High $4.06    P/E N/A 
Day Low $4.06    EPS $-1.53 
Volume 107,542